Advances in Bevacizumab Therapy for Non-small Cell Lung Cancer 
with Brain Metastases

Advances in Bevacizumab Therapy for Non-small Cell Lung Cancer 
with Brain Metastases

Brain metastases are frequently encountered in patients with non-small cell lung cancer (NSCLC) and are a significant cause of morbidity and mortality. Antiangiogenesis therapy plays a major role in the management of brain metastases in lung cancer. Bevacizumab have become the novel method for the t...

Full description

Bibliographic Details
Main Authors: Liyan QU, Rui GENG, Xia SONG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2016-08-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Brain metastases
Bevacizumab
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2016.08.05

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2016.08.05

Similar Items